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RESEARCH ARTICLE
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To analyse and compare the impact of cardiovascular risk factors and disease on health-
related quality of life (HRQoL) in people with and without diabetes living in the community.
Methods
We used data of 1,905 people with diabetes and 19,031 people without diabetes from the
last Spanish National Health Survey (years 2011–2012). The HRQoL instrument used was
the EuroQol 5D-5L, based on time trade-off scores. Matching methods were used to assess
any differences in the HRQoL in people with and without diabetes with the same characteris-
tics (age, gender, education level, and healthy lifestyle), according to cardiovascular risk
factors and diseases. Disparities were also analysed for every dimension of HRQoL: mobil-
ity, daily activities, personal care, pain/discomfort, and anxiety/depression.
Results
There were no significant differences in time trade-off scores between people with and with-
out diabetes when cardiovascular risk factors or established cardiovascular disease were
not present. However, when cardiovascular risk factors were present, the HRQoL score
was significantly lower in people with diabetes than in those without. This difference was
indeed greater when cardiovascular diseases were present. More precisely, people with dia-
betes and any of the cardiovascular risk factors, who have not yet developed any cardiovas-
cular disease, report lower HRQoL, 0.046 TTO score points over 1 (7.93 over 100 in the
VAS score) compared to those without diabetes, and 0.14 TTO score points of difference
(14.61 over 100 in the VAS score) if cardiovascular diseases were present. In fact, when the
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three risk factors were present in people with diabetes, HRQoL was significantly lower (0.10
TTO score points over 1 and 10.86 points over 100 in VAS score), obesity being the most
influential risk factor.
Conclusions
The presence of established cardiovascular disease and/or cardiovascular risk factors, spe-
cially obesity, account for impaired quality of life in people with diabetes.
Introduction
Diabetes Mellitus leads to complications associated with high social costs which greatly affect
individual and social wellbeing [1–9], reducing quality of life (QoL). Diabetes might lead to
eyesight loss due to retinopathy, the need for dialysis because of kidney failure, or amputation
because of peripheral vascular disease [6, 10]. In addition, more than 50% of patients with type
2 diabetes are over 65 years of age–as high as 62% in a recent study conducted in Catalonia
that used a population database [11]. Thus, functional impairment is a major problem in dia-
betes affecting individual autonomy and QoL [11, 12], disease-associated costs [13,14], and
with a significant prognostic value [14].
Given the complications related to diabetes and their consequences in decreasing autonomy
and wellbeing, analysing how diabetes affects health-related QoL (HRQoL) should be of great
interest not only to those with the disease, but also to health policymakers and society as a
whole. In recent years, the number of studies focused on measuring and assessing HRQoL in
people with diabetes has grown [10, 15]. The studies concluded that QoL is negatively affected
by diabetes, regardless of the evaluation tool, and that the combined prevalence of diabetes
and cardiovascular diseases is associated with a decrease in HRQoL [16, 17].
However, despite the increase in the number of studies analysing the negative association
between HRQoL and diabetes in the last decade, the literature comparing the HRQoL of peo-
ple with and without diabetes remains very scarce as well as the analyses of the potential factors
involved in this negative effect, usually limited to the role of cardiovascular disease, but ignor-
ing the one due to cardiovascular risk factors [16, 18, 19]. Moreover, no studies have compared
the HRQoL in people with and without diabetes using a representative sample of the general
population, with the use of advanced statistical methods appropriate for this purpose and iden-
tifying the dimension of HRQoL (mobility, self-care, daily activities, pain/discomfort, or anxi-
ety/depression) which are affected the most. Therefore, the main objective of this study is to
address these shortcomings by analysing and comparing the impact of both cardiovascular
risk factors and diseases on HRQoL and its domains of people with and without diabetes.
Methods
Data
Data from the last Spanish National Health Survey conducted by the National Statistics Insti-
tute in Spain was used [20]. The sample included 21,508 households with 26,502 interviews;
there were 21,007 adults (15 years or older) and 5,495 children (0–14 years). The recruitment
took place from July 2011 to June 2012 and comprised questionnaires for the households,
adults, and children. This is a cross-sectional survey, representative at a national level, and pro-
vides information on sociodemographic characteristics, physical and mental health, variables
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ics committee.
The variables of interest of this study are based on the EuroQol (EQ)-5D-5L, which is a
simple generic instrument developed by a multidisciplinary group of researchers. HRQoL is
defined in terms of 5 dimensions: mobility, self-care, daily activities, pain/discomfort, and anx-
iety/depression. The values and utilities are assigned a score on a scale based on responders’
self-reported health, where 0 corresponds to death and 1 corresponds to perfect health, with
negative values being possible. The second part of the EQ-5D-5L consists of a visual analogue
scale (VAS), on which 0 represents the worst and 100 represents the best imaginable health
state. Respondents mark a point on the scale to reflect their overall perception of health on the
day of the interview [21].
In this study, people with diabetes are defined as those who answered affirmatively to either
one of the following two questions: "Have you ever suffered from diabetes?" or "Have you ever
taken medicines for diabetes?" To define cardiovascular diseases, we include those individuals
who answered affirmatively to any of the following questions: "have you ever had (i) myocar-
dial infarction; (ii) other heart diseases; or (iii) embolism, stroke or brain haemorrhage?" Simi-
larly, individuals with cardiovascular risk factors are identified by the following questions:
"Have you ever had (i) high cholesterol or (ii) hypertension?”; (iii) a body mass index (BMI) of
30 kg/m2 or more is also considered a risk factor.
In the descriptive analysis, since the average age is much higher in people with diabetes,
based on the age distribution of people with diabetes observed in the sample (on average, 68),
S1 Table (supplementary material), a third group of people of 55 years and older without dia-
betes has also been defined in order to compare two different groups with similar age.
Statistical analysis
Different propensity matching score regressions have been applied to analyse the differences
in the HRQoL and VAS scores between people with and without diabetes. The different com-
parison groups are shown in Table 1. Due to the case assignment (being diagnosed with




People with diabetes and without cardiovascular risk factors or disease 11.9%
People with diabetes with cardiovascular risk factors and without cardiovascular
disease
63.6%
People with diabetes and established cardiovascular disease 24.5%
People without diabetes without cardiovascular risk factors or cardiovascular
disease
54.6%
People without diabetes with cardiovascular risk factors and without
cardiovascular disease
36.9%
People without diabetes with established cardiovascular disease 8.5%
People without diabetes aged55 without cardiovascular risk factors or
established cardiovascular disease
27.0%
People without diabetes aged55 with cardiovascular risk factors and without
established cardiovascular disease
55.1%
People without diabetes aged55 with established cardiovascular disease 17.9%
Source: Authors’ version, based on the 2012 National Health Survey
https://doi.org/10.1371/journal.pone.0189505.t001
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diabetes), this is not a random process, and the differences between individuals in the treat-
ment and control groups have been recorded with observable variables (such as gender, age,
education, and healthy lifestyle); a matching technique is therefore the most suitable method
[22–24].
Since we study both treated (different comparison groups) and untreated individuals (con-
trol group: not diagnosed with diabetes and no cardiovascular risk factors or disease), we are
unable to note a causal effect of interest: Yi1-Yi0, with Yi1 being the effect on the comparison
group and Yi0 being the effect on the control group. We may thus consider the Average Treat-
ment Effect on the Treatment Group (ATE):E(Y1 − Y0|X, D = 1) = E(Δ|X, D = 1), where D is a
dummy variable indicating status as belonging to the comparison group (1) or belonging to
the control group (0), and X is a vector of observable characteristics. This equation measures
the difference in the average outcome (HRQoL) of people in the comparison and control
groups.
The matching method could have been difficult to accomplish if determined by multiple
variables (meaning matching all participants in the treatment group with all participants in the
control group with the same characteristics). To avoid this problem of dimensionality, it has
been necessary to use the propensity score for determination purposes, demonstrating that if
(Y0, Y1)? D|X and 0<P (X) <1, where P(X) = Pr(D = 1|X), then, (Y0, Y1)? D|P(X); i.e., the
result for HRQoL is the same both for individuals belonging to the different comparison
groups and those belonging to the control group after adjusting for the observable characteris-
tics (X variables) [25].
The nearest-neighbour matching technique is used, as it has lower pseudo-R squared in the
probit estimation for propensity score after matching, and a lower number of treated individu-
als lost after matching.
Results
Out of the 20,936 people who had completed the EQ-5D-5L questionnaire appropriately, 1,905
(9.1% of the valid responses) had diabetes and 19,031 do not have diabetes. The main sociode-
mographic characteristics of the sample are described in S1 Table (supporting information).
The prevalence of any risk factors or cardiovascular diseases among these three groups
show remarkable differences (Table 1). While only 11.9% of the population with diabetes did
not have any cardiovascular risk factors or disease, 63.6% had any of the cardiovascular risk
factors but free from cardiovascular events and 24.5% had ever had a previous cardiovascular
episode. In contrast, 54.6% of those without diabetes had no cardiovascular risk factor nor car-
diovascular disease, 36.9% suffer from any cardiovascular risk factor, and only 8.5% had ever
had a previous cardiovascular episode. Finally, among people without diabetes aged over 55
years, 27.0% had no cardiovascular risk factors nor cardiovascular disease, 55.1% had cardio-
vascular risk factors, and 17.9% had ever suffered from a cardiovascular disease.
Table 2 shows the raw average score of the EQ-5D-5L in the three groups considered. Peo-
ple with diabetes achieve 0.781 total points in the time trade-off (TTO) score and 61 on the
VAS. Individuals without diabetes achieve higher results in both the TTO (0.921) and VAS
scores (77). Similarly, people without diabetes of 55 years and older had higher scores than
people with diabetes, but the scores were lower than those for the total sample of people with-
out diabetes (0.858 and 69 for TTO and VAS scores, respectively).
When we assess the domains of the EQ-5D-5L, several differences between the three groups
of individuals have been noted (Table 2).
Table 3 shows the results obtained after the application of statistical matching methods, dis-
playing differences in TTO and VAS scores of patients with diabetes and the control groups,
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considering the presence or absence of cardiovascular risk factors or disease. The results
showed statistically significant differences in the TTO scores between people with diabetes
and people in the control groups. More precisely, individuals with diabetes scored on average
0.069 points less on the scale of TTO scores, compared to people without diabetes or any car-
diovascular risk factors (7.94 lower in the VAS scale).
There were no differences in HRQoL between people with diabetes and without cardiovas-
cular risk factors or cardiovascular events and the control group. When people with diabetes
had any of the risk factors, their HRQoL was 0.046 points lower than that of the control group
(5.99 lower in the VAS scale) and when people with diabetes have any cardiovascular disease
their HRQoL was 0.1412 points lower than that of the control group (14.62 lower in the VAS
scale).





People without DM55 years old)
Mean (SD)
EQ-5D-5L-TTO Score 0.781 (0.247) 0.921 (0.156) 0.858 (0.201)
VAS (from 0 to 100) 61.24 (20.43) 77.17 (18.17) 69.039 (19.325)
Mobility (%)
No problems in walking about 53.7 85.4 69.5
Have slight problems in walking about 16.6 6.9 14.1
Have moderate problems in walking about 15.7 4.6 10.0
Have severe problems in walking about 10.9 2.3 5.0
Unable to walk about 2.94 0.6 1.2
Self-Care (%)
No problems washing or dressing myself 76.9 93.7 86.2
Have slight problems washing or dressing myself 8.7 2.9 6.5
Have moderate problems washing or dressing myself 6.6 1.6 3.7
Have severe problems washing or dressing myself 4.5 0.8 1.8
Unable to wash or dress myself 3.2 0.7 1.7
Usual activities (%)
No problems doing my usual activities 63.3 88.7 77.3
Have slight problems doing my usual activities 14.6 5.3 10.6
Have moderate problems doing my usual activities 10.8 3.1 6.4
Have severe problems doing my usual activities 5.3 1.4 2.9
Unable to do my usual activities 5.8 1.1 2.5
Pain/Discomfort (%)
No pain or discomfort 45.7 74.4 58.7
Have slight pain or discomfort 22.6 13.1 19.5
Have moderate pain or discomfort 20.1 8.8 14.8
Have severe pain or discomfort 10.1 3.2 6.2
Have extreme pain or discomfort 1.3 0.3 0.6
Anxiety/Depression (%)
Not anxious or depressed 71.0 85.0 78.4
Slightly anxious or depressed 14.7 8.7 11.9
Moderately anxious or depressed 9.7 4.2 6.4
Severely anxious or depressed 3.8 1.6 2.4
Extremely anxious or depressed 0.7 0.4 0.7
Source: Authors’ version, based on the National Health Survey
https://doi.org/10.1371/journal.pone.0189505.t002
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We also analysed the cumulative effect of the presence of one, two, or three of the cardiovas-
cular risk factors considered (obesity, hypertension, and/or cholesterol). We had found a dose-
response relationship; people with diabetes and only one cardiovascular risk factor had, on
average, 0.014 points less on the HRQoL scale compared to the control group (4.47 lower in
the VAS scale), reaching a difference of 0.051 points when two cardiovascular risk factors were
present (6.52 lower in the VAS scale) and 0.105 if all the three considered factors were reported
(10.86 lower in the VAS scale). Of the 0.046 less points in the HRQoL that people with diabe-
tes, with cardiovascular risk factors and without cardiovascular events have, compared to the
control group, obesity was the most influential risk factor in the deterioration of HRQoL (see
S1 Table in supporting information). More precisely, the presence of diabetes plus obesity
reduced the HRQoL by 0.042 compared to the control group. The presence of diabetes, obesity
and hypertension reduce the HRQoL by 0.06 points compared to the control group.
In general, the results of such a poorer quality of life in people with diabetes should be inter-
preted taking into consideration the results obtained in Table 1, that is, people with DM have
more cardiovascular risks and events compared to the general population (Tables 1 & 3).
An analysis of differences in each dimension of HRQOL (mobility, self-care, conducting
daily activities, pain/discomfort, and feeling depressed and/or anxious) has also been per-
formed (see supporting information S3–S7 Tables). The main dimensions accounting for the
differences in HRQOL were mobility, carrying out usual activities, and pain and/or discom-
fort. People with diabetes were 14.5 percentage points less likely to have no movement prob-
lem compared to people without diabetes or cardiovascular risk factors. Similarly, differences
Table 3. Results from matching regression analysis according to time trade-off scores and VAS
responses on the EuroQol-5D-5L.
TTO score VAS score








People with diabetes without cardiovascular risk factors or





People with diabetes with cardiovascular risk factors and without



























People without diabetes with cardiovascular risk factors and without









a people without diabetes with neither cardiovascular risk factor nor cardiovascular events
bStatistically significant at 99%. Source: Authors’ version, based on the National Health Survey Note: The
values of TTO goes from 0 (death) and 1 (the best health status), with negative values being possible,
indicating health states worse than death. The values of VAS ranges from, 0 represents the worst and 100
represents the best imaginable health state.
https://doi.org/10.1371/journal.pone.0189505.t003
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were also observed in having no problems in performing usual activities (11.2 percentage
points lower in people with diabetes) and pain and/or discomfort (15.0 percentage points
lower in people with diabetes).
Discussion
Generally, in addition to confirm the deleterious effect of diabetes on quality of life and the
role of established cardiovascular disease, our results add several novel factors: (i) a compari-
son of HRQoL in people with and without diabetes, using a representative sample of the gen-
eral population in Spain; (ii) use of advanced statistical methods for this specific purpose; (iii)
identification of the relevance of cardiovascular risk factors in people with diabetes; and (iv)
identification of the dimensions of HRQoL affected by diabetes as compared with people with-
out the disease.
The results of our study confirm that HRQoL is significantly poorer in people with diabetes.
Moreover, the presence of cardiovascular risk factors or diseases leads to significantly reduced
HRQoL in people with diabetes, in comparison to their counterparts. When people with diabe-
tes do not have any risk factors or cardiovascular disease, there is no difference in terms of
HRQoL between people with and without diabetes. However, people with diabetes and any of
the cardiovascular risk factors, who have not yet developed any cardiovascular disease, report
lower HRQoL (0.046 points) compared to the control group. In fact, when the three risk fac-
tors are present in people with diabetes, the HRQoL is significantly lower (0.10 points).
Among the risks factors, obesity is the most influential one in the deterioration of HRQoL.
More precisely, the presence of diabetes plus obesity reduces the HRQoL by 0.042 compared
to the control group. When cardiovascular diseases are present, the difference in the TTO
score reaches the highest level, 0.141 lower than the control group. These results are in line
with the literature [26].
In brief, our results are consistent with those in the literature about QoL and cardiovascular
disease in people with diabetes; signalling a greater decrease in HRQoL in individuals with dia-
betes who also have cardiovascular diseases [10, 15, 27–30], showing the role of cardiovascular
risk factors in determining lower QoL. Such poorer quality of life in people with diabetes can
mainly be explained by the fact that people with DM have more cardiovascular risks and events
compared to the general population.
Our results are also consistent with previous studies in which a negative association
between HRQoL and the type of cardiovascular disease in people with diabetes has already
been reported. The determinants of lower HRQoL in people with diabetes include both micro-
vascular (retinopathy, neuropathy, and nephropathy) and macrovascular diseases (coronary
heart disease, cerebrovascular disease, and peripheral artery disease) [27]. More specifically,
HRQoL in people with diabetes and congestive heart disease is reduced by 0.185 when the lat-
ter is the only comorbidity, and by 0.297 if there is an additional disease [31]. A Norwegian
report has showed that the factors that reduce QoL the most are stroke and neuropathy for
both diabetes types, and ischaemic heart disease for type 1 diabetes [32]. The association
between cardiovascular diseases, diabetes, and QoL has also been shown in the KORA study of
a German population, in which stroke, neuropathy, and myocardial infarction more negatively
affect the QoL of individuals with diabetes [28]. Similarly, British researchers from the United
Kingdom Prospective Diabetes Study (UKPDS) have reported the same negative impact of car-
diovascular diseases [29].
It is hard to compare the results of this study with previous studies due to the lack of litera-
ture comparing HRQOL in populations with or without diabetes. The only previous Spanish
study evaluating HRQoL in people with and without diabetes was conducted in 2003 [30]. In
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the CODE-2 Spanish, 1,000 participants cared for in primary care centres completed the EQ-
5D-5L. When comparing people with type 2 diabetes with a matched population without dia-
betes, the former had worse scores in all components of the EQ-5D-5L; the scores were espe-
cially poor in those with diabetes and chronic micro- and macrovascular complications.
According to the data used in our analysis, other chronic diseases such as osteoarthritis,
COPD or tumours have been found to also reduce HRQoL in 0.179, 0.1414 and 0.1312 TTO
score points, respectively. These results are in line with literature. Those suffering from COPD
have between 0.05 and 0.18 (depending on the severity of the disease) TTO score points less
compared to those who do not [33, 34]. Alike, those with osteoarthritis have on average 0.08
TTO [35]. Apparently, it may seem that the loss of HRQoL that DM causes is modest com-
pared to those caused by such diseases. However, in order to interpret properly these figures, it
should be taken into consideration the information provided in Table 2, as it indicates that
most people who suffer from DM also have vascular risk factors and/or cardiovascular dis-
eases. The combined effects of these elements make the loss of HRQoL associated with DM
comparable to the three diseases mentioned previously.
In our study, HRQoL has also been analysed by dimension (mobility, self-care, daily activi-
ties, pain and discomfort, and anxiety/depression). The main differences between people with
diabetes and the control group are shown in mobility, daily activities, and feeling pain or dis-
comfort. More specifically, people with diabetes are 14.5 percentage points more likely to have
mobility problems in comparison to those with neither diabetes nor any cardiovascular risk
factors or diseases (control group). Furthermore, people with diabetes are 11.2 percentage
points more likely to have difficulties with daily activities, and 15 percentage points more likely
to feel pain or discomfort, in comparison to the control group. However, very few interna-
tional studies have used large samples to compare different dimensions of HRQoL between
people with and without diabetes [36, 37]. Notwithstanding, our results cannot be directly
compared to those obtained from these studies, as they applied different instruments to mea-
sure HRQoL. Moreover, they only reported a descriptive analysis based on the percentages of
people with and without diabetes in each HRQoL dimension, and did not show the differences
for each dimension of HRQoL between people with and without diabetes, as we have done.
With regards to the limitations of the study, given the nature of the data, it has not been
possible to perform a longitudinal analysis of individual health status over time, which would
enable a deeper knowledge of changes in HRQoL when groups are diagnosed with diabetes or
cardiovascular risk factors, or survive a cardiovascular event. On the other hand, the body
mass index has been estimated based on the available data for weight and height given by the
respondents, so answers can be sensitive to potential misreporting and recall bias or even to
social norms [38, 39]. Additionally, this survey has the advantage of being representative of the
general Spanish population, and includes extensive information on not only the sociodemo-
graphic characteristics, but also on the health status of the population and the utilization of
healthcare resources; however, it is not a survey specifically designed to study health problems
in people with diabetes. For this reason, the effect of specific diabetes complications with great
impact in HRQOL as neuropathy, retinopathy, amputations or hypoglycaemia [27–32] could
not be identified. Moreover, as there is a significant percentage of undiagnosed patients, some
people who have denied having diabetes could actually have the disease [40].
Conclusion
In brief, our findings suggest; (i) there are no significant differences on HRQoL of people with
diabetes without cardiovascular risk factor or cardiovascular events vs people without diabetes
without cardiovascular risk factor or cardiovascular events; (ii) when different cardiovascular
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risks and cardiovascular disease are present, differences between people with or without diabe-
tes become statistically significant and negative; (iii) the cardiovascular risk which has the
highest impact on HRQoL of people with diabetes is obesity; and (iv) cardiovascular disease
has a stronger impact in the deterioration of HRQoL than any other cardiovascular risk factor,
even when people with diabetes have the presence up to the three of them. Although the size of
the effect estimated in this study may look small, the results are quite relevant from a clinical
point of view, as it is necessary to consider that cardiovascular disease is the most frequent
complication in people with diabetes, especially in older people with diabetes, representing
more than 50% of people with diabetes. Moreover, diabetes is one of the leading causes of an
increase in Disability-Adjusted Life Years (DALYs) recently reported by the Global Burden of
Disease Study [41] and one of the potential explanations for this impairment comes from the
effect of diabetes on cardiovascular diseases, which promotes disability and finally impact on
QoL, Accordingly, our results could be of great value for the design, implementation, and eval-
uation of preventive policies and therapeutic programs focused on reducing the incidence and
prevalence of cardiovascular risk factors, mainly obesity, and cardiovascular diseases, which
reduce quality of life the most. The identification of programs and interventions that bring
together a rational and efficient use of resources, with elements of distributive equity in terms
of access and benefits, is compulsory for health authorities. In this study, we have tried to
report information that quantifies the potential loss in quality of life that might be avoided
with programmes brought to the population with diabetes. However, it remains to be seen
whether programs aimed at improving glycaemic control could prevent or delay negative
health shocks.
Supporting information
S1 Table. Main sociodemographic characteristics of the sample.
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S2 Table. Results from the matching regressions detailed by cardiovascular risk factor.
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